Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Prologis | PLD | Jan 15, 2025 | 107.85 | -0.25 |
ProMIS Neurosciences | PMN | Jan 15, 2025 | 0.91 | -3.02 |
PropertyGuru | PGRU | Jan 15, 2025 | 6.70 | 0.00 |
ProPetro | PUMP | Jan 15, 2025 | 10.72 | +2.19 |
ProPhase Labs | PRPH | Jan 15, 2025 | 0.60 | -0.89 |
ProQR Therapeutics | PRQR | Jan 15, 2025 | 2.29 | +1.33 |
PROS | PRO | Jan 15, 2025 | 22.25 | +1.37 |
ProShares Bitcoin Strategy ETF | BITO | Jan 15, 2025 | 24.22 | +3.33 |
Proshares Ultra FTSE Europe | UPV | Jan 15, 2025 | 55.62 | +2.48 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Jan 15, 2025 | 31.00 | -8.50 |
Proshares Ultrashort FTSE Europe | EPV | Jan 15, 2025 | 40.72 | -2.65 |
Prospect Capital | PSEC | Jan 15, 2025 | 4.29 | +0.47 |
Prospect Capital A Pref | PSEC-A | Jan 15, 2025 | 17.03 | +0.59 |
Prosperity Bancshares | PB | Jan 15, 2025 | 78.83 | +1.59 |
Protagenic Therapeutics | PTIX | Jan 15, 2025 | 0.46 | -2.05 |
Protagonist Therapeutics | PTGX | Jan 15, 2025 | 37.94 | +3.46 |
Protalix Bio Therapeutics | PLX | Jan 15, 2025 | 2.17 | -0.46 |
Protara Therapeutics | TARA | Jan 15, 2025 | 4.67 | -7.16 |
Prothena | PRTA | Jan 15, 2025 | 13.27 | +4.74 |
Proto Labs | PRLB | Jan 15, 2025 | 38.26 | +3.10 |
Provident Bancorp | PVBC | Jan 15, 2025 | 11.03 | +1.85 |
Provident Financial | PROV | Jan 15, 2025 | 14.85 | -0.80 |
Provident Financial Services | PFS | Jan 15, 2025 | 19.36 | +1.36 |
Prudential ADR | PUK | Jan 15, 2025 | 15.03 | +1.97 |
Prudential Financial | PRU | Jan 15, 2025 | 120.06 | +2.08 |
Ps International Group | PSIG | Jan 15, 2025 | 0.44 | +4.39 |
PSQ Holdings | PSQH | Jan 15, 2025 | 4.13 | +12.84 |
Psyence Biomedical | PBM | Jan 15, 2025 | 1.64 | -9.89 |
PT Telkom Indonesia (Persero) Tbk ADR | TLK | Jan 15, 2025 | 16.42 | +0.31 |
PTC | PTC | Jan 15, 2025 | 185.37 | -0.07 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.